Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution. (Q52537663)

2 May 2018

title

Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution. (English)

1 reference

2 May 2018

1 reference

Birnbaum Y

1

1 reference

2 May 2018

Atar S

2

1 reference

2 May 2018

Luo H

3

1 reference

2 May 2018

Nagai T

4

1 reference

2 May 2018

Siegel RJ

5

1 reference

2 May 2018

publication date

1 December 1999

1 reference

2 May 2018

published in

Thrombosis Research

1 reference

2 May 2018

volume

96

1 reference

2 May 2018

issue

6

1 reference

2 May 2018

page(s)

451-458

1 reference

2 May 2018

Platelet GPIIb-IIIa blockers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Ultrasound-assisted thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Ultrasound accelerates urokinase-induced thrombolysis and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Enhancement of thrombolysis by ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Does external ultrasound accelerate thrombolysis? Results from a rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Transcutaneous ultrasound augments lysis of arterial thrombi in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Ultrasound enhancement of rabbit femoral artery thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Ultrasound enhanced thrombolysis in experimental retinal vein occlusion in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Albumin Microbubble Echo-Contrast Material as an Enhancer for Ultrasound Accelerated Thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

New antiplatelet agents for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Intravascular therapeutic ultrasound thrombolysis in acute myocardial infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

Release of β-Thromboglobulin from Human Platelets by Therapeutic Intensities of Ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900139-5

7 January 2021

10.1016/S0049-3848(99)00139-5

Identifiers

DOI

1 reference

2 May 2018

1 reference

2 May 2018